Deborah Kronenberg-Versteeg

Associate Fellow and Postdoctoral Researcher, Cambridge Institute for Medical Research
Year Joined Homerton: 
  • Skowera A, Ladell K, McLaren JE, Dolton G, Matthews KK, Gostick E, Kronenberg-Versteeg D, Eichmann E, Knight RR, Heck S, Powrie J, Bingley PJ, Dayan CM, Miles JJ, Sewell AK, Price DA, Peakman M. ß-Cell-Specific CD8 T cell phenotype in Type 1 Diabetes Reflects Chronic Autoantigen Exposure. Diabetes, 2015, 64 (3).
  • Knight RR, Dolton G, Kronenberg-Versteeg D, Eichmann M, Zhao M, Huang GC, Sewell AK, Skowera A, Peakman M. A distinct immunogenic region of GAD65 is naturally processed and presented by human islet cells to cytotoxic CD8 T cells. Clin Exp Immunol, 2015, 179 (1).
  • Eichmann M, de Ru A, van Veelen P, Peakman M, Kronenberg-Versteeg D. Identification and Characterisation of Peptide Binding Motifs of Six Autoimmune Disease-Associated Human Leukocyte Antigen-Class I Molecules including HLA-B*39:06. Tissue Antigens, 2014, 84 (4).
  • Arif S, Leete P, Nguyen V, Marks K, Nor NM, Estorninho M, Kronenberg-Versteeg D, Bingley PB, Todd J, Guy C, Dunger D, Tremble JM, Powrie J, Willcox A, Foulis AK, Richardson SJ, de Rinaldis E, Morgan NG, Lorenc A, Peakman M. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes, 2014, 63 (11).
  • Dolton G, Lissina A, Skowera A, Ladell K, Tungatt K, Jones E, Kronenberg-Versteeg D, Akpovwa H, Pentier J, Holland C, Godkin A, Cole D, Neller M, Miles J, Sewell A. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T-cells. Clin Exp Immunol, 2014, 177 (1).
  • Estorninho M, Gibson V, Kronenberg-Versteeg D, Ni C, Cerosaletti K, Peakman M. Tracking antigen-experienced CD4 T-cells via tandem deep and shallow T-cell receptor clonotyping. Journal of Immunology, 2013, 191 (11).
  • Leung R, Simmons A, Proitis P, Guntert A, Kronenberg D, Pritchard M, Tsolaki M, Mecocci P, Kloszwska I, Vellas B, Soininen H, Wahlund LO, Lovestone S. Inflammatory proteins in plasma are associated with severity of Alzheimer’s disease. PLOS One, 2013, 8 (6).
  • Knight RR, Kronenberg D, Zhao M, Huang GC, Bulek A, Woolridge L, Cole DK, Sewell AK, Peakman M, Skowera A. Human β-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon TCR avidity. Diabetes, 2013, 62 (1).
  • Kronenberg D, Knight RR, Estorninho M, Ellis RJ, Kester MG, de Ru A, Eichmann M, Huang GC, Powrie J, Dayan CM, Skowera A, van Veelen PA, Peakman M. Circulating, preproinsulin signal peptide-specific CD8 T-cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of Type 1 diabetes and kill β-cells. Diabetes, 2012, 61 (7).
  • Furney S, Kronenberg D, Simmons A, Guentert A, Dobson RJ, Proitsi P, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S.  Combinatorial markers of mild cognitive impairment conversion to Alzheimer’s disease – cytokines and MRI measures together predict disease progression. J Alzheimers Dis, 2011, 26 Suppl 3.
  • Krull M, Pistor S, Voss N, Kel A, Reuter I, Kronenberg D, Michael H, Schwarzer K, Potapov A, Choi C, Kel-Margoulis O, Wingender E. TRANSPATH®: An Information Resource for Storing and Visualizing Signaling Pathways and their Pathological Aberrations. Nucleic Acid Res, 2006 Jan 01; 34.